Ling Wang

Title: Ling Wang: Innovator in Hepatitis B Virus Detection

Introduction

Ling Wang is a prominent inventor based in Dublin, California. She has made significant contributions to the field of molecular diagnostics, particularly in the detection of hepatitis B virus (HBV). Her innovative work has led to advancements in the methods used for the rapid detection of HBV in various samples.

Latest Patents

Ling Wang holds a patent for "Compositions and methods for amplification and detection of hepatitis B virus RNA, including HBV RNA transcribed from cccDNA." This patent describes methods for the rapid detection of the presence or absence of HBV in biological or non-biological samples. The methods include an amplifying step, a hybridizing step, and a detecting step. Additionally, the patent provides primers, competitive blocking oligonucleotides, and probes specifically targeting HBV RNA, particularly HBV RNA transcribed from cccDNA, such as pgRNA.

Career Highlights

Ling Wang is currently employed at Roche Molecular Systems, Inc., where she continues to develop innovative solutions in molecular diagnostics. Her work has been instrumental in enhancing the accuracy and efficiency of HBV detection methods.

Collaborations

Ling Wang has collaborated with notable colleagues, including Jeffery Fong and Aaron T Hamilton. These collaborations have further enriched her research and contributed to the advancement of diagnostic technologies.

Conclusion

Ling Wang's contributions to the field of hepatitis B virus detection exemplify her dedication to innovation in molecular diagnostics. Her patented methods and ongoing work at Roche Molecular Systems, Inc. highlight her role as a leading inventor in this critical area of healthcare.